This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The 2024 version of the LI-RADS Ultrasound Surveillance system improves detection of hepatocellular carcinoma (HCC) over earlier iterations, a study published January 22 in the American Journal of Roentgenology found. Researchers led by Sang Hyun Choi, MD, PhD, from the University of Ulsan in Seoul, South Korea found that LI-RADS version 2024 (v2024) leads to higher sensitivity but lower specificity for HCC detection compared to LI-RADS version 2017 (v2017).
People often ask me what I think will/does happen when private equity groups fail. The answer I’ve always said is it probably depends. The work needs to get done, so there are three big options: Direct hospital/system employment probably with locums in the short term New private practice Outsourced to teleradiology firm (potentially with IR/DR split and locus/direct employment for on-site procedural work) There was a story this past summer in Radiology Business that I don’t think I s
Using a deep-learning model with lung CT imaging shows promise for identifying and segmenting tumors, researchers have reported. The study results could have important implications for lung cancer treatment, according to lead author Mehr Kashyap, MD, of Stanford University School of Medicine. The findings were published January 21 in Radiology. "Our study represents an important step toward automating lung tumor identification and segmentation," Kashyap said in a statement released by the RSNA.
Amidst rising cancer prevalence and soaring costs, new cancer technologies and innovations are emerging to support the early detection, treatment, and surveillance of cancer. Read this guide to understand how to evaluate these solutions for your employees and members – and to learn more about the current state of coverage, clinical and cost effectiveness, and impact on quality and outcomes.
Cardiovascular AI software developer HeartFlow has partnered with the Boone Heart Institute in Greenwood Village, CO, to launch Gamefilm Registry, a data collection effort to define cardiac risk in retired National Football League (NFL) players. The registry will enroll 120 retired NFL players to assess cardiovascular risks using HeartFlows advanced imaging and AI-powered analysis tools, such as its Fractional Flow Reserve-CT (FFR-CT) software, which uses CT scans to calculate how much blood is
Incidence rates among women 50 to 64 have now surpassed those of men, while cancer rates for females under 50 are 82% higher than their male counterparts, the ACS reports.
284
284
Sign up to get articles personalized to your interests!
Diagnostic Imaging Brief brings together the best content for architecture professionals from the widest variety of industry thought leaders.
Incidence rates among women 50 to 64 have now surpassed those of men, while cancer rates for females under 50 are 82% higher than their male counterparts, the ACS reports.
Life Molecular Imaging has secured fast-track designation from the U.S. Food and Drug Administration (FDA) for its amyloid PET radiotracer for visualizing cardiac amyloid light-chain (AL) and amyloid transthyretin-related (ATTR) amyloidosis. F-18 florbetaben (Neuraceq) is already approved in the U.S. and Europe and is widely used to diagnose patients with Alzheimers disease based on amyloid deposits in the brain.
I signed up for my Threads and Bluesky accounts in addition to OG Twitter/X or even LinkedIn a while back but never started really using them (@benwhitemd across the board). I’ve now set those up so that I can more easily share tweets of new blog posts across all platforms to account for reader preference (and I even added the cute little logos to the sidebar).
Patient-centric scheduling can only be achieved through optimized radiology workflows, effective communications between staff and physicians, and, of course, through specialized schedulers. In this guide, we’ll take you through a step-by-step process to transform your radiology center into a high-performance hub of medical imaging.
Hologic has received a warning letter from the U.S. Food and Drug Administration (FDA) for not addressing violations related to the companys BioZorb 3D bioabsorbable radiographic markers. The letter follows a previous warning by the FDA to consumers, healthcare providers, and healthcare facilities not to use the markers as well as a voluntary recall by Hologic, both issued in October.
Early detection remains one of the most powerful tools in the fight against breast cancer. Yet traditional paper-based screening methods have limited the ability to consistently identify high-risk patients. That’s why Midstate Radiology Associates adopted the Ambry CARE Program (CARE) to improve universal cancer risk stratification. Jenna Cooke, DNP, APRN, FNP-C, CGRA provides an overview of this advanced digital screening tool, designed to improve access, accuracy and patient outcomes.
Matthew Lee, MD. Image courtesy of the ARRS. The American Roentgen Ray Society (ARRS) has awarded two $180,000 scholarships to radiologists Matthew Lee, MD, and Luca Pasquini, MD, PhD. The ARRS Scholarships are granted to support early-career faculty members pursuing radiological research that promises to change how medical imaging is practiced, the ARRS said.
About 40% of us will be diagnosed with cancer in our lifetime, and patients are getting younger. At the same time, the cost of treatment continues to rise, with employers spending 8.5% more on cancer care for each employee than they did last year. The best thing employers can do for their employees and business tomorrow is to invest in cancer detection and care today.
Intelerad Medical Systems has entered a partnership with Carpl.ai to integrate Carpl.ai's AI orchestration platform into Intelerad's partner platform. The integration is supported by InteleGence, Intelerads integration platform, which allows users to access a curated ecosystem of AI solutions, now including Carpl.ais marketplace of more than 140 AI applications.
An emerging deep learning radiomics model based on biparametric MRI (bpMRI) offered a 14 to 17 percent higher AUC range than PI-RADS scoring for predicting the aggressiveness of prostate cancer, according to new research findings.
Siemens Healthineers has installed the first Mammomat B.brilliant mammography system in the U.S. at an imaging center in Iowa run by Grace Breast Imaging & Medical Spa. Mammomat B.brilliant is the first completely redesigned mammography system by Siemens in over a decade, the company noted. The system introduces new technology that enables wide-angle tomosynthesis acquisitions in under five seconds and a detector and new x-ray tube that uses flying focal-spot technology adapted from the comp
Researchers have developed a breakthrough method to detect inflammation in the body using positron emission tomography (PET) imaging. This innovative probe targets CD45, a marker abundantly expressed on all immune cells but absent from other cell types.
Discover how Color's comprehensive care solution is revolutionizing cancer screening adherence and knowledge. Through an in-depth case study, Color's unique approach to comprehensive cancer care has shown significant benefits in increasing screening rates and enhancing patient knowledge. Participants reported a 2-3x increase in adherence to screening guidelines over just 8 weeks, with 84% of participants increasing their familiarity with timing and frequency of cancer screening.
The latest ultrasound software update from Clarius includes new artificial intelligence (AI) capabilities, coding assistance and a variety of advances tailored to different fields of medicine.
Researchers have developed a groundbreaking method to expand the palette of bioluminescent protein colors for cell labeling. By creating 20 distinct colors, they have enabled the simultaneous detection of multiple labeled cells using a standard camera. This innovative approach simplifies the tracking of individual cells within a population and holds significant potential for applications such as monitoring cell fate or identifying rare cells with unique responses to drugs.
Previously approved for the detection of neuritic beta amyloid plaque, the PET agent (18F)florbetaben is currently being evaluated in a phase 3 multicenter trial for the diagnosis of cardiac amyloidosis.
A new molecular imaging technique -- 18F-FAPI PET -- can detect the first signs of tissue remodeling in patients with pulmonary arterial hypertension (PAH), providing physicians with an early marker for disease progression. This approach has the potential to pave the way for more personalized management of PAH, offering more timely interventions to improve patient prognosis.
Explore the latest insights from the American Cancer Society's “Cancer Statistics 2024” report, which unveils multiple alarming trends in cancer data. Cancer is on the rise among young adults, and diagnoses for 6 of the 10 most common cancers are escalating. With over 2 million new cancer cases projected in the U.S. this year, employers face increased challenges when it comes to supporting employees.
X-Ray images provide crucial insights, enabling accurate diagnosis of fractures, infections, and other medical conditions efficiently. The post An Introduction on How to Read X-Ray Images appeared first on Open MedScience.
This research aimed to develop and assess a Lipiodol Pickering emulsion containing anti-Programmed cell Death Ligand 1 (PD-L1) antibodies through in vitro experiments.
Challenges of proton therapy include high costs, technical complexities, limited evidence, and accessibility issues for patients worldwide. The post Proton Therapy: An Examination of Challenges and Future Directions appeared first on Open MedScience.
As HR and Benefits leaders are in the midst of evaluating cancer care solutions and designing their requirements for vendors, it’s key to know what questions to ask to ensure the development of a truly comprehensive strategy: from prevention to diagnosis to treatment to survivorship. Getting to the right answers starts with asking the right questions: How can better access improve engagement?
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
290 
Let's personalize your content